Market cap
$2,214 Mln
Revenue (TTM)
$246 Mln
P/E Ratio
--
P/B Ratio
96.1
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-26.3
-
Debt to Equity
12.1
-
Book Value
$--
-
EPS
$-1.3
-
Face value
--
-
Shares outstanding
29,801,891
9 Years Aggregate
CFO
$-290.14 Mln
EBITDA
$-258.77 Mln
Net Profit
$-350.87 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Establishment Labs Holdings (ESTA)
| 3.3 | -2.8 | 1.3 | 92.9 | 10.6 | 0.0 | -- |
|
BSE Sensex*
| -11.7 | -4.8 | 1.7 | -7.5 | 3.9 | 5.1 | 9.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Establishment Labs Holdings (ESTA)
| 58.2 | -60.6 | -2.9 | 79.6 | 36.1 | 0.9 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Establishment Labs Holdings (ESTA)
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The... company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas. Read more
-
Founder, CEO & Executive Director
Mr. Juan Jose Chacon Quiros
-
Founder, CEO & Executive Director
Mr. Juan Jose Chacon Quiros
-
Headquarters
Austin, TX
-
Website
FAQs for Establishment Labs Holdings (ESTA)
What is the current share price of Establishment Labs Holdings Inc (ESTA) Today?
The share price of Establishment Labs Holdings Inc (ESTA) is $75.29 (NASDAQ) as of 08-Sep-2026 16:00 EDT. Establishment Labs Holdings Inc (ESTA) has given a return of 10.63% in the last 3 years.
What is the current PB & PE ratio of Establishment Labs Holdings Inc (ESTA)?
Since, TTM earnings of Establishment Labs Holdings Inc (ESTA) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-42.28 |
91.68 |
2024 |
-15.76 |
25.11 |
2023 |
-8.60 |
36.68 |
2022 |
-21.31 |
-195.77 |
2021 |
-39.58 |
32.09 |
What is the 52 Week High and Low of Establishment Labs Holdings Inc (ESTA)?
The 52-week high and low of Establishment Labs Holdings Inc (ESTA) are Rs 97.40 and Rs 36.53 as of 09-Sep-2026.
What is the market cap of Establishment Labs Holdings Inc (ESTA)?
Establishment Labs Holdings Inc (ESTA) has a market capitalisation of $ 2,214 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Establishment Labs Holdings Inc (ESTA)?
Before investing in Establishment Labs Holdings Inc (ESTA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.